MIA:


  • WHO ATC First Level (Anatomical main group) ID: C CARDIOVASCULAR SYSTEM
  • WHO ATC Second Level (Therapeutic subgroup) ID: C01 CARDIAC THERAPY
  • WHO ATC Third Level (Pharmacological subgroup) ID: C01A CARDIAC GLYCOSIDES
  • WHO ATC Fourth Level (Chemical subgroup) ID: C01AC Strophantus glycosides
  • WHO ATC Fifth Level (Chemical substance) ID: C01AC01 G-strophanthin

  • Chemical Name: Ouabain
  • Chemical Smi: OC[C@@]12[C@H](O)C[C@@H](C[C@@]2(O)CC[C@@H]2[C@@H]1[C@H](O)C[C@]1([C@]2(O)CC[C@@H]1C1=CC(=O)OC1)C)O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O

  • WHO ICD Mapped Level : I50 I50 Name: Heart failure
  • WHO ICD Fourth Level ID: Name:
  • WHO ICD Third Level ID: I50 I50 Name: Heart failure
  • WHO ICD Second Level ID: I30-I52 I30-I52 Name: Other forms of heart disease
  • WHO ICD First Level ID: IX IX Name: Diseases of the circulatory system